ATAI Life Sciences takes in $24m

ATAI Life Sciences, a biotech company focused on ending mental illnesses, has raised $24 million in convertible note financing.

24 April 2020•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Credit Healthcare Briefs